- Screening and testing for drug-resistant tuberculosis (TB) infection presents a vast avenue, Awareness about tuberculosis makes Asia Pacific promising market
- Culture-based assays made rapid penetration in tuberculosis testing market, drug-resistant TB presents a tall challenge for healthcare systems
ALBANY, N.Y., June 9, 2021 /PRNewswire/ -- Tuberculosis testing has advanced continuously over the years to help in the diagnosis of TB and occupies a key role in preventing its transmission. Adoption of infection control practices has propelled healthcare providers in collaboration with government to identify at-risk populations. The high mortality of pulmonary tuberculosis has led to remarkable advancements in culture-based tests.
Tests to identify Mycobacterium tuberculosis in the body, a gold standard for testing, has been extensively helpful in reducing the burden of active tuberculosis. Advances in such tests are expanding the avenue in the tuberculosis testing market. However, Mantoux TST needs a follow-up tests, and has shown limited success in confirming TB disease in the individual. The lack of TST antigen is a key factor for its limited efficacy in developing world.
The global tuberculosis testing market stood at US$ 2.5 Bn in 2018 and is expected to reach US$ 3,399.8 Mn with the CAGR of 4.0% from 2019 to 2027.
Unmet Need in Latent TB detection to Drive Innovations: The tuberculosis treatment market has evolved on the back of focus on targeted testing in at-risk populations. Particularly, the market is seeing new avenues from the use of testing to promote treatment of latent tuberculosis infection which has high worldwide burden. In the U.S. alone, per the CDC, as many as 13 million people are living with latent TB infection. Case detection for latent TB infections plays a crucial role in reducing tuberculosis prevention, mainly by identifying at-risk populations. In this regard, targeted testing is viewed as an effective approach for reducing the future cases of tuberculosis disease, hereby reducing the burden.
Prevalence of Drug-Resistant Tuberculosis Infection Propels Need for Screening: presence of drug-resistant (DR) tuberculosis pose a massive concern for healthcare systems. Per the WHO, there are over half a million new cases of DR TB that are rifampicin-resistant (RR) and multidrug-resistant (MDR). The worrying thing is that the cohort that had undergone treatment shows poor treatment completion rates. Hence, the agency is regularly updating its MDR-TB treatment guidelines. Players in the TB testing market rely on drug susceptibility testing (DST) to identify the source case of DR-TB.
Growing Awareness of TB and Affordability of Tests in Hospitals Boosts Market
Developing regions of the world are seeing rise in awareness of the morbidity of TB and the treatment regimens available at low cost. Hospitals are a key site for TB testing, and they are keen on making such tests affordable. This will expand the revenue prospects in the TB testing market.
Tuberculosis Testing Market: Regional Prospects
Of all the regions, North America held the majority of shares in the global market in 2018
Strides in bacteriological confirmation, especially screening for drug resistant tuberculosis infection, had made the region generate sizable revenues over the years
Asia Pacific is expected to see substantially lucrative avenues through 2027
The growth of the market is likely to be fueled by efforts by NGOs in raising awareness about TB, and launch of better products in the key economies of the region
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through adhoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision."